Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Autolus to Present at Upcoming Investor Conferences

Autolus
Posted on: 31 Aug 18

LONDON, UK, August 30, 2018 - Autolus Therapeutics plc (NASDAQ: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that management will be participating in the following, upcoming investor conferences:

 

  • Dr. Christian Itin, chief executive officer, will present at the Wells Fargo 13th Annual Healthcare Conference on Wednesday, September 5, at 9:40 a.m. ET in Boston, MA. A webcast of the presentation will be available on the investor relations section of the company’s website: https://www.autolus.com
  • Christopher Vann, chief operating officer, will present at the H.C. Wainwright 20th Annual Global Investment Conference on Thursday, September 6, at 3:50 p.m. ET in New York, NY
  • Dr. Itin will present at the 16th Annual Morgan Stanley Global Healthcare Conference on Wednesday, September 12, at 3:50 p.m. ET in New York, NY. A webcast of the company’s fireside chat will be available on the investor relations section of Autolus’ website: https://www.autolus.com

 

 

About Autolus Therapeutics plc

Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defense mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors. For more information, go to: https://www.autolus.com

 

 

 

Investor Contact:                               International Media Contact             U.S. Media Contact:

S.A. Noonan Communications, LLC    JW Communications                          Rx Communications Group, LLC

Susan A. Noonan                                Julia Wilson                                        Paula Schwartz

+1-212-966-3650                                +44 (0)7818 430877                            + 1-917-322-2216

susan@sanoonan.com                       juliawilsonuk@gmail.com                  pschwartz@rxir.com

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 01/09/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.